Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Equities researchers at Wedbush increased their Q3 2023 earnings per share estimates for shares of Apellis Pharmaceuticals in a research report issued on Thursday, October 5th. Wedbush analyst L. Chico now anticipates that the company will post earnings per share of ($0.95) for the quarter, up from […]
Nur Nicholson Sells 20,350 Shares of Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Insider Selling: Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Insider Sells 12,000 Shares of Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Candriam S.C.A. boosted its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 59.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 443,507 shares of the company’s stock after acquiring an additional 165,000 shares during the period. Candriam S.C.A. […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) CEO Cedric Francois sold 150,000 shares of the stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $41.75, for a total transaction of $6,262,500.00. Following the sale, the chief executive officer now directly owns 424,655 shares of […]